Ledger.Open graph →
SEC Form D · Amendment · filed January 13, 2025

Cambrian BioPharma Inc

Offering
$37.6M
Sold
$23.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Maryanna G. Saenko · New York, NYDirectorPaul G. Farr · New York, NYDirectorJames G. Peyer · New York, NYExec · DirectorChristian G. Angermayer · New York, NYDirectorPaul G. Farr · New York, NYDirectorBrian D. Martin · PACIFIC PALISADES, CADirectorAron Shapiro · Encinitas, CADirectorTravis Kell · Santa Monica, CAExec · DirectorBrenton G. Saunders · New York, NYDirectorJeffery C. Schneider · MOORESTOWN, NJExec · DirectorMatthew Gaylord · Waltham, MADirectorRobert S. Newell · Las Vegas, NVDirectorBrenton G. Saunders · New York, NYDirectorJohn D. Lerosen · PACIFIC PALISADES, CADirectorAnton Zietsman · Santa Monica, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗